Iron addiction: A novel therapeutic target in ovarian cancer

Ovarian cancer is a lethal malignancy that has not seen a major therapeutic advance in over 30 years. We demonstrate that ovarian cancer exhibits a targetable alteration in iron metabolism. Ferroportin (FPN), the iron efflux pump, is decreased, and transferrin receptor (TFR1), the iron importer, is...

Descripción completa

Detalles Bibliográficos
Autores principales: Basuli, Debargha, Tesfay, Lia, Deng, Zhiyong, Paul, Bibbin, Yamamoto, Yusuke, Ning, Gang, Xian, Wa, McKeon, Frank, Lynch, Miranda, Crum, Christopher P., Hegde, Poornima, Brewer, Molly, Wang, Xiaohong, Miller, Lance D., Dyment, Nathaniel, Torti, Frank M., Torti, Suzy V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540148/
https://www.ncbi.nlm.nih.gov/pubmed/28319068
http://dx.doi.org/10.1038/onc.2017.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540148/
https://www.ncbi.nlm.nih.gov/pubmed/28319068
http://dx.doi.org/10.1038/onc.2017.11

Ejemplares similares